21 October 2013
2QFY14 Results Update | Sector:
Cement
Ultratech Cement
BSE SENSEX
20,883
Bloomberg
Equity Shares (m)
M.Cap. INR b/USD b
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
S&P CNX
6,189
UTCEM IN
274.2
538.1/8.6
2,066/1,405
10/-8/-15
CMP: INR1,964
TP: INR1,925
Neutral
Profitability below estimates on lower realizations, higher cost
Ultratech Cement's (UTCEM) 2QFY14 performance is below estimates, with
blended EBITDA/ton of INR704 (-INR360 YoY, -INR320 QoQ) v/s est. INR889/ton,
impacted by lower realizations and higher cost.
Grey cement volumes stood at 9.23mt (-0.6% YoY, -9% QoQ v/s est. 9.06mt). Grey
cement realizations declined ~3.6% QoQ (-6% YoY) to INR3,973/ton.
EBITDA de-grew 34% YoY (37% QoQ) to INR6.6b (v/s est. INR8.2b), translating
into blended EBITDA/ton of INR704 (-INR360 YoY, -INR320 QoQ).
Costs inflation was higher-than-expected on account of RM/energy and other
expenses. Further lower other income, higher interest cost and higher tax further
impacted PAT at ~INR2.6b, a de-growth of 52% YoY (61% QoQ).
We downgrade FY14E/FY15E EPS estimates by 10%/7% to INR86/INR103 to factor
weaker volumes and pricing. We also factor for realization improvement of
~INR7.5/INR10/INR10 per bag in 3Q/4QFY14E/FY15E and volume growth
assumption of 2%/9.6% in FY14E/FY15E.
Based on our preliminary estimates for consolidation of Jaypee’s Gujarat plant,
the stock trades at 19.1x FY15E EPS, 10.4x EV/EBITDA and USD132/ton. Current
valuations largely factor for potential recovery in FY15, benefit of which would be
diluted due to initial impact of Jaypee’s Gujarat plant acquisition by 1HFY15.
Downgrade to
Neutral
with a target price of INR1,925 (10x FY15E EV/EBITDA).
Financials & Valuation (INR B)
Y/E MAR
2013 2014E 2015E
Net Sales
200.2 207.6 239.1
EBITDA
Adj PAT
Adj.EPS.INR
Gr. (%)
BV/Sh.(INR)
RoE (%)
RoCE (%)
P/E (x)
P/BV (X)
45.2
26.6
96.8
10.4
555.7
18.9
21.4
20.3
3.5
42.1
23.7
86.4
-10.8
630.4
14.6
16.8
22.7
3.1
51.2
28.2
102.9
19.1
719.3
15.2
18.5
19.1
2.7
Jinesh Gandhi
(Jinesh@MotilalOswal.com); +91 22 3982 5416
Sandipan Pal
(Sandipan.Pal@MotilalOswal.com); +91 22 3982 5436
Investors are advised to refer through disclosures made at the end of the Research Report.